Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking with his Northern Irish counterpart to ensure that radioisotopes are distributed to areas most in need.

The Department has been working hard with industry to help resolve the shortages of radioisotopes, which are affecting the United Kingdom and other countries around the world. The affected radioisotopes are mainly used for diagnosing cancers, including prostate and breast cancer, and are also used for the imaging of organ function in scans, including for the heart. Despite efforts to limit the impact, there will be delays for some patients accessing services which rely on this affected radioisotope, with potential cancellations. In the most urgent cases patients will be prioritised for care while supplies are limited. Patients may also be offered the necessary treatment at another hospital.

The Department is working in close partnership with National Health Service specialists from across the UK, suppliers, the British Nuclear Medicine Society, UK Radiopharmacy Group, and the devolved administrations, including Northern Ireland, to ensure that critical patients are prioritised and the limited supply is shared equitably between hospitals and trusts across the UK.

The Department has worked with specialist clinicians to develop comprehensive management advice for NHS clinicians across the UK on how to manage and prioritise patients affected by these shortages. The guidance covers actions for health boards in the devolved nations, including on the coordination of mutual aid arrangements and escalation routes where issues are identified.